Skip to content

Evaluation of Indices of Body Composition During Ultramarathon : Measure by Body Bioelectrical Impedance

Evaluation of Indices of Body Composition During Ultramarathon : Measure by Body Bioelectrical Impedance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01906203
Acronym
IMPETRAIL
Enrollment
200
Registered
2013-07-24
Start date
2013-05-31
Completion date
2013-09-30
Last updated
2014-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Keywords

Ultramarathon, bioelectrical impedance, Phase-Angle

Brief summary

Prospective cohort, monocentric non-randomized and interventional clinical study in ICU assessing the evolution of body composition using bioelectrical impedance analysis.

Detailed description

Prospective, monocentric non-randomized and interventional clinical study in ICU assessing the evolution of body composition using bioelectrical impedance analysis (phase angle, fat mass, muscle mass, fat-free mass, body water) before and after ultramarathon.

Interventions

DEVICEbody bioelectrical impedance performed by Z-Métrix (class IIa) - BIOPARHOM 12 allée des lacs de garde, Savoie Technolac BP 238, 73374 Bourget du lac, France

Sponsors

University Hospital, Estaing
CollaboratorOTHER
University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participation to ultramarathon

Exclusion criteria

* pregnancy women

Design outcomes

Primary

MeasureTime frame
Difference of fat-free mass, using bioelectrical impedance analysisbefore and after ultramarathon of 105 km (at day 1)

Secondary

MeasureTime frame
Difference of phase angle, using bioelectrical impedance analysisat day 1(before and after ultramarathon)
Correlation between order in the course,duration of course and indices of body compositionat day 1 (during ultramarathon of 105 km)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026